PHI with Exogenous allergic bronchial asthma
How does this condition affect your private health insurance?
Exogen allergisches Asthma bronchiale, also known as extrinsic or allergic asthma, is a chronic inflammatory airway disease triggered by specific environmental allergens such as pollen, dust mites, or pet dander. It often manifests in childhood and involves the immune system's overreaction, leading to airway inflammation, bronchoconstriction, and increased mucus production. Symptoms include recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly exacerbated by allergen exposure. Genetic predisposition plays a significant role. Management focuses on allergen avoidance, bronchodilators for symptom relief, and inhaled corticosteroids to control underlying inflammation and prevent acute exacerbations, thereby improving quality of life.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute attacks can last from minutes to hours, while exposure during peak allergen seasons can lead to persistent symptoms over several days to weeks.
Duration of Illness (Lifetime)
Chronic disease, often lifelong, though symptom severity and frequency can fluctuate over time and may improve in some individuals after childhood.
Cost of Treatment (Initial)
Varies from a few hundred USD for outpatient treatment of a mild attack to several thousand USD (e.g., 500-5000 USD) for an emergency room visit or hospitalization for a severe exacerbation.
Cost of Treatment (Lifetime)
Significant, ranging from several thousands to tens of thousands of USD over a lifetime (e.g., 10,000-50,000+ USD), including medication (daily inhalers), regular doctor visits, allergy testing, and potential emergency care.
Mortality Rate
Low with proper management, typically less than 0.1% annually, but increases significantly in severe, uncontrolled cases or during life-threatening acute exacerbations without prompt treatment.
Risk of Secondary Damages
Moderate to high. Potential long-term consequences include airway remodeling, reduced lung function, increased susceptibility to respiratory infections, psychological impact (anxiety, depression), and reduced quality of life. Side effects from long-term medication use are also possible.
Probability of Full Recovery
Low. While some children experience remission, particularly after puberty, the underlying allergic predisposition often remains. A complete 'cure' is rare, with most requiring ongoing management to control symptoms and prevent exacerbations. Long-term remission might occur in 10-30% of cases.
Underlying Disease Risk
High. Frequently co-occurs with other atopic conditions such as allergic rhinitis (hay fever), atopic dermatitis (eczema), and food allergies. Increased risk for gastroesophageal reflux disease (GERD), sleep apnea, and mental health conditions like anxiety or depression.